We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+16.87%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$478M
AUM Growth
+$21.6M
(+4.7%)
Cap. Flow
-$9.41M
Cap. Flow
% of AUM
-1.97%
Top 10 Holdings %
Top 10 Hldgs %
39.23%
Holding
111
New
20
Increased
19
Reduced
33
Closed
21
Top Buys
| 1 |
Centene
CNC
|
+$13.5M |
| 2 |
Cigna
CI
|
+$9.96M |
| 3 |
Merck
MRK
|
+$9.66M |
| 4 |
Icon
ICLR
|
+$9.38M |
| 5 |
GSK
GSK
|
+$9.35M |
Top Sells
| 1 |
AstraZeneca
AZN
|
+$13.1M |
| 2 |
Cencora
COR
|
+$12.5M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$12.3M |
| 4 |
Sanofi
SNY
|
+$10.7M |
| 5 |
Amgen
AMGN
|
+$9.2M |
Sector Composition
| 1 | Healthcare | 90.08% |
| 2 | Consumer Staples | 1.38% |
| 3 | Technology | 0.69% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Curis
CRIS
$9.06M
| $49.6M | 10.37% |
10,954
-937
| -8% | -$3.92M |
|
|
2
Cigna
CI
$80.2B
| $25.9M | 5.41% |
106,965
+44,700
| +72% | +$9.96M |
|
3
Cardinal Health
CAH
$53.9B
| $16.7M | 3.49% |
274,917
+119,700
| +77% | +$6.61M |
|
4
SPDR Gold Trust
GLD
$131B
| $15.5M | 3.24% |
97,009
-5,500
| -5% | -$924K |
|
|
SOLY
5
DELISTED
Soliton, Inc.
SOLY
| $14.5M | 3.03% |
824,803
-37,602
| -4% | -$481K |
|
|
6
Centene
CNC
$33.9B
| $13.9M | 2.91% |
+217,500
| New | +$13.5M |
|
7
HCA Healthcare
HCA
$80.7B
| $13.8M | 2.88% |
73,173
-7,572
| -9% | -$1.34M |
|
|
SPRB
8
Spruce Biosciences
SPRB
$128M
| $13.5M | 2.82% |
10,838
+2,349
| +28% | +$3.61M |
|
9
Coherus Oncology
CHRS
$224M
| $12.4M | 2.59% |
847,862
-16,194
| -2% | -$275K |
|
|
HRC
10
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $11.9M | 2.49% |
107,647
-15,551
| -13% | -$1.62M |
|
|
11
Merck
MRK
$298B
| $9.64M | 2.01% |
+131,000
| New | +$9.66M |
|
|
ALBO
12
DELISTED
Albireo Pharma Inc
ALBO
| $9.46M | 1.98% |
268,346
-85,864
| -24% | -$3.17M |
|
13
United Therapeutics
UTHR
$22.4B
| $9.37M | 1.96% |
56,044
+17,310
| +45% | +$2.89M |
|
|
14
Icon
ICLR
$13B
| $9.33M | 1.95% |
+47,500
| New | +$9.38M |
|
|
15
GSK
GSK
$103B
| $9.19M | 1.92% |
+206,000
| New | +$9.35M |
|
16
AMN Healthcare
AMN
$1.26B
| $9.13M | 1.91% |
123,898
-6,700
| -5% | -$498K |
|
17
Universal Health Services
UHS
$8.73B
| $9.09M | 1.9% |
68,135
-12,708
| -16% | -$1.69M |
|
|
EPIX
18
DELISTED
ESSA Pharma
EPIX
| $9.08M | 1.9% |
312,711
-120,312
| -28% | -$2.8M |
|
19
Mirum Pharmaceuticals
MIRM
$7.37B
| $8.66M | 1.81% |
437,138
-57,605
| -12% | -$1.1M |
|
|
BLRX
20
BioLineRX
BLRX
$13.3M
| $7.65M | 1.6% |
+68,544
| New | +$8.24M |
|
21
McKesson
MCK
$94.1B
| $7.59M | 1.59% |
38,893
-8,569
| -18% | -$1.56M |
|
22
X4 Pharmaceuticals
XFOR
$379M
| $6.93M | 1.45% |
+26,820
| New | +$7.05M |
|
23
Herbalife
HLF
$1.27B
| $6.6M | 1.38% |
148,719
+71,059
| +92% | +$3.5M |
|
|
RCOR
24
DELISTED
Renovacor, Inc.
RCOR
| $6.41M | 1.34% |
+600,000
| New | +$6.21M |
|
25
Teva Pharmaceuticals
TEVA
$37.1B
| $6.23M | 1.3% |
539,947
-150,439
| -22% | -$1.73M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA